| 000 | 01373 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513200937.0 | ||
| 264 | 0 | _c20000224 | |
| 008 | 200002s 0 0 spa d | ||
| 022 | _a0036-4355 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlbertengo, M E | |
| 245 | 0 | 0 |
_a[Recombinant human erythropoietin: method of in vivo evaluation using normocythemic mice]. _h[electronic resource] |
| 260 |
_bSangre _cOct 1999 |
||
| 300 |
_a357-63 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiological Assay _xeconomics |
| 650 | 0 | 4 | _aCell Separation |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aErythrocyte Count _xdrug effects |
| 650 | 0 | 4 |
_aErythropoietin _xadministration & dosage |
| 650 | 0 | 4 | _aEvaluation Studies as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aQuality Control |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aReticulocyte Count _xdrug effects |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 700 | 1 | _aValcarce, G A | |
| 700 | 1 | _aOliva, L M | |
| 700 | 1 | _aBaiges, D L | |
| 700 | 1 | _aAlonso, B S | |
| 700 | 1 | _aChiale, C A | |
| 773 | 0 |
_tSangre _gvol. 44 _gno. 5 _gp. 357-63 |
|
| 999 |
_c10574555 _d10574555 |
||